54 -4 (78) 2025 - Ismailova J.A., Abdurahimov A.A. - MORPHOLOGICAL STUDIES AS A TOOL FOR EARLY DIAGNOSIS OF STOMACH CANCER: THE SIGNIFICANCE OF H. PYLORI STRAINS

MORPHOLOGICAL STUDIES AS A TOOL FOR EARLY DIAGNOSIS OF STOMACH CANCER: THE SIGNIFICANCE OF H. PYLORI STRAINS

Ismailova J.A. - Republican specialized scientific and practical Center for Therapy and Medical Rehabilitation Uzbekistan

Abdurahimov A.A. - The Center for Advanced Technologies, Uzbekistan

Rahimova Sh.Sh. - Republican specialized scientific and practical Center for Therapy and Medical Rehabilitation Uzbekistan

Resume

With the aim of early diagnosis of stomach cancer, the authors studied the significance of morphological studies and pathogenic strains of H. pylori in 100 patients with gastric diseases infected with H. pylori and in a control group of 20 individuals. The results of the study showed that a mild degree of gastric mucosal damage by H. pylori in chronic gastritis is associated with low intensity of inflammatory changes, and the CagA gene can be considered a marker gene indicating the pathogenicity status of H. pylori.

Keywords: H. pylori, chronic gastritis, endoscopic studies, gastric mucosa, ureC and CagA genes, biopsy, molecular genetic studies, OLGA and OLGIM systems, atrophy, intestinal metaplasia.

First page

327

Last page

332

For citation:Ismailova J.A., Abdurahimov A.A., Rahimova Sh.Sh. - MORPHOLOGICAL STUDIES AS A TOOL FOR EARLY DIAGNOSIS OF STOMACH CANCER: THE SIGNIFICANCE OF H. PYLORI STRAINS//New Day in Medicine 4(78)2025 327-332 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

1. Абдурахимов А.А. Гастриты, ассоциированные с Helicobacter pylori: Автореф. дисс. … канд. мед. наук. –Т., 2014; 24 с.
2. Бордин Д.С., Ливзан М. Консенсус Маастрихт VI опубликован: что нового? Эффективная фармакотерапия. 2022;18(22):72–84.
3. Юсупбеков А.А., Исмаилова Ж.А. Genetic aspects of Helicobacter pylori in gastric diseases. - Тиббиётда янги кун 2023;6(56):264-270 https://newdayworldmedicine.com/en/article/2061
4. Díaz P., Valenzuela Valderrama M., Bravo J., Quest A.F.G. Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression. Front. Microbiol. 2018;9:ID5.
5. Fallone C. A., Chiba N., van Zanten S. V., Fischbach L., Gisbert J. P., Hunt R. H., et al. (2016). The toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 2016;151:51-69. e14. doi: 10.1053/j.gastro.2016.04.006.
6. Ismailova J.A., Yusupbekov A.A. Modern aspects to the problem of the prevalence of helicobacter pylori associated stomach diseases in Uzbekistan. Journal of Healthcare in Developing Countries (JHCDC). Selangor. 2021;1(2):28-30.
7. Graham D.Y. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits- Gastroenterology. 2015;148(4):719-731.
8. Olar L., Mitruţ P., Florou C., Mălăescu G.D., Predescu O.I., Marcela L.R., Mogoantă L., Ionovici N., Pirici I., Evaluation of Helicobacter pylori infection in patients with eso-gastro-duodenal pathology. Rom J Morphol Embryol. 2017;58(3):809-815.
9. Malfertheiner P., F. Megraud, C. O'morain et al., “Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report,” Gut, vol. 66, no. 1, pp. 6–30, 2017.
10. Sugano K., Tack J., Kuipers E.J. et al. Kyoto global consensus report on Helicobacter pylori gastritis - Gut. 2015;64(9):1353-1367.
11. Wald N. J. The treatment of Helicobacter pylori infection of the stomach in relation to the possible prevention of gastric cancer. In: IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, № 8); 2014; 174-18.
12. Hooi J.K.Y., Lai W.Y., Ng W.K., Suen M.M.Y, Underwood FE, Tanyingoh D, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420-9. https: doi. org/10.1053/j.gastro.2017.04.022.

    file

    download